Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Effector Therapeutics Inc (NQ: EFTR ) 0.1800 UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Effector Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > 3 Publicly Traded Companies Filing for Bankruptcy as July Kicks Off July 15, 2024 Explore bankruptcy risk stocks with insights on Chicken Soup for the Soul Entertainment, eFFECTOR Therapeutics, and Delta Apparel. Via InvestorPlace Topics Bankruptcy Exposures Financial Legal Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday June 26, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! Via InvestorPlace Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher June 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70% June 24, 2024 EFFECTOR Therapeutics shares are trading lower by 74% during Monday's session. The company announced that it has terminated its employees and will wind down its operations. Via Benzinga eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq June 24, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer May 20, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire EFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024 May 09, 2024 EFTR stock results show that eFFECTOR Therapeutics met analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 09, 2024 Via Benzinga eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire eFFECTOR Therapeutics to Participate in Upcoming Investor Conference April 09, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session April 05, 2024 Via Benzinga Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results April 04, 2024 U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88.... Via Benzinga Topics Stocks Exposures US Equities Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 04, 2024 Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 04, 2024 Via Benzinga Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings April 04, 2024 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P... Via Benzinga Topics Stocks Exposures US Equities Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data April 04, 2024 eFFECTOR Therapeutics unveils Phase 2 KICKSTART trial results for tomivosertib with Keytruda in NSCLC patients. Tomivosertib shows modest activity, but no clear path forward. Zotatifin emerges as a... Via Benzinga Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000 April 04, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 39,259.15 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer April 04, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday March 26, 2024 It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning! Via InvestorPlace EFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023 March 25, 2024 EFTR stock results show that eFFECTOR Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 25, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session March 08, 2024 Via Benzinga eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference February 05, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules January 29, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules January 25, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 25, 2024 Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session January 24, 2024 Via Benzinga Dow Tumbles Over 200 Points; US Trade Gap Narrows In November January 09, 2024 U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 09, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.